Clinical Trials

Beech Tree Labs currently collaborates with Norwich Clinical Research Associates Ltd. for regulatory submissions and management of clinical trials. The Company is currently conducting FDA-authorized trials targeting recurrent oral herpes and urinary incontinence.

Beech Tree investigators have prior experience conducting 14 successful FDA-authorized clinical trials, 4 Institutional Review Board (IRB)-approved clinical trials, and 2 USDA clinical trials, all focusing on Resonant Molecular Signaling agents.  These include:

FDA Phase 2

  • Acute myelogenous leukemia (AML) [2]
  • Cancer-associated pain
  • Myelodysplastic syndrome (MDS) [2]
  • Prostate cancer, advanced
  • Solid tumors
  • Benign prostatic hyperplasia (BPH) [2, 1 failed]
  • Chronic prostatitis
  • Chronic bronchitis
  • Chronic obstructive pulmonary disease (COPD)
  • Cystic fibrosis
  • Chronic fatigue syndrome
  • Multiple sclerosis

Institutional Review Board (IRB)

  • Cancer-associated pain
  • Cardiomyopathy
  • Osteoporosis
  • Urinary incontinence

USDA

  • Canine mast cell tumors
  • Equine myositis
Copyright Beech Tree Labs, Inc.